QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
QQQ   258.54 (-2.06%)
AAPL   381.91 (-0.46%)
MSFT   207.07 (-3.09%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
CGC   17.30 (-0.69%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
ACB   12.08 (+0.50%)
GILD   76.68 (+0.47%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
BA   175.65 (-1.56%)
Log in

NYSEARCA:SBIOALPS Medical Breakthroughs ETF Stock Price, Forecast & News

$42.03
-0.35 (-0.83 %)
(As of 07/13/2020 04:00 PM ET)
Add
Today's Range
$41.92
Now: $42.03
$42.64
50-Day Range
$39.51
MA: $42.02
$44.14
52-Week Range
$25.10
Now: $42.03
$45.02
Volume13,700 shs
Average Volume57,254 shs
Market Capitalization$191.24 million
P/E RatioN/A
Dividend Yield0.04%
BetaN/A

Geographic Exposure of SBIO

Currency Exposure of SBIO

Sector Exposure of SBIO

Industry Exposure of SBIO


Basic Details

Issuer Alps
Fund NameALPS Medical Breakthroughs ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:SBIO
Inception Date12/31/2014
Fund ManagerRyan Mischker, Andrew Hicks
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkPoliwogg Medical Breakthroughs Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$191.46 million
Average Daily Volume$30,974.70
Discount/Premium-0.05%

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorALPS Fund Services, Inc.
AdvisorALPS Advisors, Inc.
CustodianState Street Bank and Trust Company
DistributorALPS Portfolio Solutions Distributor, Inc.
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerCantor Fitzgerald

Receive SBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for SBIO and its competitors with MarketBeat's FREE daily newsletter.

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Frequently Asked Questions

How has ALPS Medical Breakthroughs ETF's stock been impacted by COVID-19 (Coronavirus)?

ALPS Medical Breakthroughs ETF's stock was trading at $33.59 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SBIO stock has increased by 25.1% and is now trading at $42.03. View which stocks have been most impacted by Coronavirus.

How often does ALPS Medical Breakthroughs ETF pay dividends? What is the dividend yield for ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF announced an annual dividend on Thursday, December 19th. Shareholders of record on Friday, December 20th will be given a dividend of $0.0159 per share on Friday, December 27th. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, December 19th. View ALPS Medical Breakthroughs ETF's dividend history.

Has ALPS Medical Breakthroughs ETF been receiving favorable news coverage?

News stories about SBIO stock have trended very negative on Monday, according to InfoTrie. The research group identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ALPS Medical Breakthroughs ETF earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about ALPS Medical Breakthroughs ETF.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Inovio Pharmaceuticals (INO), Johnson & Johnson (JNJ), Marina Biotech (MRNA), Novavax (NVAX), Sanofi (SNY), Walmart (WMT) and Cidara Therapeutics (CDTX).

What is ALPS Medical Breakthroughs ETF's stock symbol?

ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SBIO."

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Summit Financial Group Inc. (0.18%) and Envestnet Asset Management Inc. (0.13%).

Which major investors are buying ALPS Medical Breakthroughs ETF stock?

SBIO stock was bought by a variety of institutional investors in the last quarter, including Summit Financial Group Inc., and Envestnet Asset Management Inc..

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ALPS Medical Breakthroughs ETF's stock price today?

One share of SBIO stock can currently be purchased for approximately $42.03.

How big of a company is ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF has a market capitalization of $191.24 million.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.